Term
Antidysrhythmics: 3 key drugs |
|
Definition
lidocaine (Xylocaine)
amiodarone (Cordarone)
adenosine (Adenocard)
|
|
|
Term
Antidysrhythmic: lidocaine (Xylocaine)
Classification and Uses
|
|
Definition
Class Ib - block sodium channel, delay repolarization, éAPD
Used to treat PVCs (with more than 6 at a time) and V-tach
Lidocaine (Xylocaine) treats only _ventricular_ dysrhythmias.
|
|
|
Term
Antidysrhythmic: amiodarone (Cordarone)
Classification and Uses
|
|
Definition
Class III - drugs whose principal effect on cardiac tissue is to é APD
Uses: V-tach or supraventricular (V fib and V flutter) and A fib
Amiodarone (Cordarone) treats both _atrial_ and _ventricular_ dysrhythmias.
|
|
|
Term
Antidysrhythmic: adenosine (Adenocard)
Classification and Uses
|
|
Definition
Half-life: 8-10 sec
Causes transient asystolic pause
Class V - antidysrhythmic
Used to convert supraventricular tachycardia (SVT) to normal sinus rhythm
|
|
|
Term
Antidysrhythmics: Overall mechanisms of actions and drug effects |
|
Definition
Antidysrhythmics are used to alter the action potential of cardiac cells (alter some aspect of myocardial conduction to prevent dysrhythmias), making them less responsive to intrinsic electrical stimuli.
|
|
|
Term
Antidysrhythmics: Overall Indications |
|
Definition
Dysrhythmias
(Any abnormality in cardiac automaticity or impulse conduction will result in some type of dysrhythmia)
Class I – prolong depolarization, diminish mycocaridal excitation, depress conduction
Class III – alter repolarization (longer), slows HR
Treat fast heart rhythms
Often times used when nothing else has worked – have horrible AEs (pro-arhythmic – can cause lethal dysrhythmias)
|
|
|
Term
Antidyrhythmics: lidocaine (Xylocaine
AEs |
|
Definition
CNS toxicities like twitching, convulsions, confusion; respiratory depression or arrest
CV - Hypotension, bradycardia, and dysrhythmias
|
|
|
Term
Antidysrhythmics: amiodarone (Cordarone)
AEs |
|
Definition
Lipophilic – penetrates and concentrates the adipose tissue where it produces unwanted effects (any fatty tissue of the body)
Hyper/hypothyroidism, corneal micro deposits: halos, photophobias and dry eyes
Pulmonary toxicity (progressive dyspnea and cough accompanied by damage to alveoli) – can result in pulmonary fibrosis
PROARYTHMIC - while it treats dysrhythmias, it may also provoke them
|
|
|
Term
Antidysrhythmics: Interactions |
|
Definition
enhanced anticoagulant effect with anticoagulants (bleeding)
proarrhythmic effect with other antidysrhythmic agents (cardiac arrest). |
|
|
Term
Antidyrhythmics: General Assessment |
|
Definition
Always want to check pulse and BP before administering drugs
Watch coagulant effects
|
|
|
Term
Antidysrhythmics: Assessment
With lidocaine (Xylocaine), important to assess what systems?
|
|
Definition
CV (with attention to HR and BP) and CNS
|
|
|
Term
Antidysrhythmics: Assessment
With amiodarone (Cordarone), important to assess what conditions?
|
|
Definition
Respiratory, thyroid, hepatic and/or hypertensive conditions
|
|
|
Term
Antidysrhythmics: Implementation
|
|
Definition
Antidysrhythmics given IV should always be on an infusion pump.
Amiodarone (Cordarone) may cause GI upset (commonly occurs during admin of loading dose).
|
|
|
Term
Antidysrhythmics: Evaluation
Class I – What CNS-related effects will you look for?
|
|
Definition
Confusion and convulsions
|
|
|
Term
Antidysrhythmics: Evaluation
What should you assess with Class III drugs? |
|
Definition
Assess pulmonary function tests and thyroid function. |
|
|
Term
Antidysrhythmics: Patient Teaching |
|
Definition
No caffeine – increase HR
Take with food – potential GI upset
Take antacids 2 hrs before or after – interfere with absorption
Photosensitivity – watch sunlight exposure
|
|
|